GSE132739
RNA-seq analysis of murine microglial BV2 cells treated with interferon-gamma (IFN?)
BV2 cells were treated with IFN?. Wildtype cells were compared to cells made deficient for Atg5 via CRISPR/Cas9. Overall design: Independent biological replicates for each condition were pooled in a single library.